INVESTIGATION OF THE TOXICITY AND EFFLUX OF POLYCHLORINATED BIPHENYLS AND HYDROXYLATED POLYCHLORINATED BIPHENYLS IN \u3cem\u3eESCHERICHIA COLI\u3c/em\u3e by Geng, Shen
University of Kentucky 
UKnowledge 
University of Kentucky Master's Theses Graduate School 
2011 
INVESTIGATION OF THE TOXICITY AND EFFLUX OF 
POLYCHLORINATED BIPHENYLS AND HYDROXYLATED 
POLYCHLORINATED BIPHENYLS IN ESCHERICHIA COLI 
Shen Geng 
University of Kentucky, gengshen065@gmail.com 
Right click to open a feedback form in a new tab to let us know how this document benefits you. 
Recommended Citation 
Geng, Shen, "INVESTIGATION OF THE TOXICITY AND EFFLUX OF POLYCHLORINATED BIPHENYLS AND 
HYDROXYLATED POLYCHLORINATED BIPHENYLS IN ESCHERICHIA COLI" (2011). University of Kentucky 
Master's Theses. 133. 
https://uknowledge.uky.edu/gradschool_theses/133 
This Thesis is brought to you for free and open access by the Graduate School at UKnowledge. It has been accepted 
for inclusion in University of Kentucky Master's Theses by an authorized administrator of UKnowledge. For more 
information, please contact UKnowledge@lsv.uky.edu. 
  
ABSTRACT OF THESIS 
 
INVESTIGATION OF THE TOXICITY AND EFFLUX  
OF POLYCHLORINATED BIPHENYLS AND HYDROXYLATED 
POLYCHLORINATED BIPHENYLS IN ESCHERICHIA COLI 
 
Polychlorinated biphenyls (PCBs) are persistent organic pollutants. Due to 
their properties, PCBs accumulate in the food-chain and post a threat to the health of 
human beings and wildlife. Hydroxylated PCBs (OH-PCBs) are oxidative metabolites 
of PCBs and are more hydrophilic than their parent PCBs. One of the best approaches 
to break down these contaminants is through bioremediation, which is an 
environmental friendly process that uses microorganisms to restore natural 
environment.  
Towards this goal, we have investigated the toxicity and accumulation of 
PCBs and OH-PCBs in a Gram-negative bacterium, Escherichia coli. We have also 
determined the role played by a primary multidrug efflux transporter AcrB on the 
accumulation of PCBs and OH-PCBs in bacterial cell. We found that none of the 
PCBs tested was toxic to E. coli, while different OH-PCBs have different levels of 
toxicity; the acrB knockout strain accumulated significantly more PCBs and 
OH-PCBs than the wild-type strain, suggesting that these compounds are substrates of 
the efflux pump; higher cytoplasmic concentrations of OH-PCBs were also observed 
in the acrB knockout strain using the biosensors. Based on these observations, we 
conclude that both PCBs and OH-PCBs are substrates of protein AcrB. Therefore the 
efflux activities of multidrug resistant pumps in Gram-negative bacteria should be 
considered while designing bioremediation approaches.  
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Chapter I: Introduction 
 
1.1 Polychlorinated biphenyl (PCB), an environmental pollutant 
 
PCBs are a group of synthetic compounds that are among the most notorious 
environmental contaminants. PCBs were widely used in industrial applications, 
particularly as electrical insulating and heat-exchange fluids in transformers and heat 
insulators since 1920s [Kucewicz, 2004]. Concerns over PCBs developed in 1965 
after the detection of trace amount of these compounds in wildlife in Sweden [Jensen, 
1969]. Later in 1979, upon the identification of PCBs in environmental samples, U.S. 
government banned the production of PCBs and began to strictly regulate the use of 
PCBs in industry. However, due to years of intensive use, improper disposal, and the 
intrinsic resistance of the compounds to degradation, large quantities of PCBs remain 
in the natural environment, corresponding to one-third of the 1.1 billion tons of PCBs 
ever produced [Weigel and Wu, 2000]. PCBs can be found in air, water, soils, and 
wildlife, posing a threat to all living creatures.  
 
Because of their highly hydrophobic nature, PCBs preferentially adsorb on the 
surface of sediment at the bottoms of rivers. After being ingested by bottom feeders, 
PCBs accumulate along the food chain and circulate in the global ecosystem. PCBs 
have been found in about one-third of the Superfund National Priorities Sites [EPA, 
2000]. Although considerable efforts have focused on cleaning up PCBs from the 
environment over the past couple of decades, large amount of PCBs still exist in the 
environment, threatening the well-being of both humans and wildlife [Ballschmitter, 
1991].  
 
1.1.1 Structure and property of PCBs 
 
There are 209 PCB congeners. All PCB molecules have a biphenyl backbone 
as shown in Figure 1.1. Except for the two carbons that serve as the connecting sites, 
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the other ten carbons may attach either a hydrogen or a chlorine atom. According to 
the IUPAC nomenclature, the ring with more substitutions or substitutions that occur 
on carbons with smaller numbers in the biphenyl assembly is given unprimed 
numbers and the other ring with primed numbers. It has been found that the higher the 
degree of chlorine substitution, the harder the corresponding PCB to degrade. As a 
consequence, the most common PCBs that are detected from exposed animals are 
usually with high levels of chlorination, including 2, 2’, 3, 4, 4’, 
5-hexachlorobiphenyl, 2, 2’, 4, 4’ 5, 5’-hexachlorobiphenyl, and 2, 2’, 3, 4, 4’, 5, 
5’-heptachlorobiphenyl [McFarland and Clarke, 1989].  
 
In terms of structures, PCBs fall into two categories: co-planar structures 
(dioxin-like PCBs) and non-planar structures (non-dioxin-like PCBs). The toxicity of 
co-planar PCBs is much higher than that of non-planar PCBs [Safe, 1993]. As for the 
synthesis of PCBs, two main methods have been adopted, including ferric ion and 
iron-catalyzed chlorination of biphenyls [Schaeffer, et al. 1984]. The chlorination is 
nevertheless non-region specific, which results in the formation of a complex mixture 
of isomers and congeners [Safe, 1993].  
 
 
Figure 1.1. The general structure of PCBs. 
 
PCBs are chemically inert to different types of chemical reactions including 
oxidation, reduction, addition, and substitution. They are also resistant to treatments 
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with acid, base, and heat. These qualities make PCBs very desirable in industrial 
applications, especially for the manufacturing of coolants and lubricants. However, 
these characteristics also make PCBs persistent environmental pollutants since they 
do not readily break down when exposed to chemical treatments or heat. Another 
characteristic that makes PCBs notorious pollutants lies in their hydrophobicity. They 
tend to accumulate in the fat tissues of oily fish (e.g. salmon, herring, sardines, tuna, 
and swordfish). PCBs in tissues from animals higher in the food chain that consume 
these fishes may reach a concentration that is many thousands of times higher than the 
PCB concentration in water. PCBs have been found all over the world including in the 
Arctic and Antarctic regions [Kucewicz, 2004]. Recently, it was reported that high 
levels of PCBs were found in polar bears [Skaare, et al. 2000]. Fish is also a food 
source for humans. Thus, it is not a surprise that detectable amounts of PCBs are 
widely found in human serum, adipose tissue, and breast milk, particularly from those 
who often consume contaminated fish [Buck, et al. 1997]. 
 
1.1.2 Adverse health effects of PCBs 
 
Scientists have established connections between PCB exposure and adverse 
health effects. Laboratory animals have been shown to develop tumors under 
conditions of high-dose PCB exposure. U.S. Environmental Protection Agency, as 
well as other governmental or advisory agencies, classified PCBs as known animal 
carcinogens and possible human carcinogens. PCBs also attribute to eye irritations 
and skin disorders, such as chloracne in workers who were exposed to high levels of 
PCBs by skin contact and /or inhalation [James, 1993].  
 
Excessive exposure to PCBs also affects the nervous system, immune system, 
reproductive system, and endocrine system. Studies with monkeys and humans reveal 
that exposure to PCBs leads to deficits in neurological development and changes in 
activity [Kimbrough, 2001]. PCBs have also been shown to suppress the immune 
system and therefore increase the risk of infections [EPA, 2008]. Reproductive defects 
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have been studied in a variety of animal species as well as humans who were exposed 
to PCB. Women who worked with PCBs in factories gave birth to children with 
decreased birth weights and gestational age [EPA, 2008]. PCBs have also been 
associated with type-2 diabetes through a study involving Swedish fishermen who 
consume contaminated fish from Baltic Sea [Lee, et al. 2006]. A positive correlation 
between levels of PCBs in their serum and prevalence of type-2 diabetes in the 
population has been established [Rylander, 2005].  
 
1.1.3 Bioremediation of PCB contamination sites 
 
Traditional methods to remedy PCB contamination sites include incineration, 
vitrification, solvent extraction and land filling [ATSDR, 1993]. However, these 
methods have the disadvantages of being time-consuming, expensive, and incomplete. 
In the last decade, many researchers began to focus on the development of an 
alternative approach to break down PCB wastes using microbes.  
 
Microorganisms belonging to both Gram-negative and Gran-positive genera 
including Pseudomonas, Alcaligenes, Achromobacter, Rhodococcus, 
Corynebacterium, and Bacillus have been isolated from PCB contaminated sites 
[Unterman, et al. 1996]. These microbes are capable of growing on biphenyl as the 
sole carbon source. In 1973, Ahmed and Focht first reported that Achromobacter is 
capable of degrading several PCBs [Ahmed, et al. 1973]. Thereafter, the 
biodegradation of PCBs was explored from two aspects, dechlorination by anaerobic 
bacteria and oxidative degradation by aerobic ones [Furukawa and Fujihara, 2008].  
 
The aerobic PCB degradation bacteria have a bph gene cluster which is 
present on their genomes or plasmids. These genes code for enzymes that are capable 
of catalyzing different steps of the reaction. Along the biphenyl degradative passway, 
one chlorinated benzoic acid and one dienoic acid are generated from the degradation 
of one chlorobiphenyl molecule as shown in Figure 1.2 [Gu, et al. 2004]. In terms of 
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dechlorination, microorganisms such as Dehalococcoides and Thermotogales are able 
to remove flanking chlorines on several PCBs. Dechlorination is expected to reduce 
the toxicity of PCBs as well as making them more susceptible to aerobic 
degradation[Liu, et al. 2010]. 
 
 
 
Figure 1.2. Biodegradation of PCBs catalyzed by Bhp proteins. One molecule of cis-2, 
3-dihydro-2, 3-dihydroxychlorobiphenyls is generated from chlorobiphenyl in the presence of 
BphA. BphB catalyzes the next step to produce 2, 3-hydroxychlorobiphenyl. BphC and BphD 
catalyzes the next two steps of reactions and eventually generate one chlorobenzoic acid and one 
2-hydroxy-penta-2, 3-dienoic acid [Gu, et al. 2004]. 
 
1.2 Hydroxylated polychlorinated biphenyls (OH-PCBs) 
 
OH-PCBs are hydroxylated metabolites of polychlorinated biphenyls, with a 
common structure shown in Figure 1.3. The major metabolic pathway of PCBs is 
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biotransformation mediated by the cytochrome P450 isozymes, the terminal oxidases 
of the hepatic mixed-function oxidase system, to form hydroxylated PCBs [Lehmler, 
et al. 2010]. Even the most persistent PCB congeners can be transformed into a 
number of hydroxylated metabolites over time. Aerobic microorganisms degrade 
PCBs through another metabolic pathway to generate OH-PCBs with two hydroxyl 
substitutions on the parental PCBs, which are catalyzed by terminal dioxygenases. 
Furthermore, these OH-PCBs undergo degradation to form chlorinated benzoic acids 
[Furukawa and Fujihara, 2008]. Abiotically, OH-PCBs may form via reactions of 
gaseous PCBs with OH radicals generated by UV degradation of ozone [Ueno, et al. 
2007]. An inverse relationship between PCB concentration and OH radicals in the 
contaminated atmosphere has been reported, suggesting the hydroxylation of PCBs as 
the major removal pathway for PCBs in the atmosphere.  
 
 
Figure 1.3. The general structure of monohydroxylated PCBs. 
 
There are 837 possible monohydroxylated polychlorinated biphenyl congeners 
compared to 209 PCB congeners. The presence of hydroxyl groups renders these 
compounds more hydrophilic than their parent PCBs. Due to increased solubility, 
OH-PCBs are more readily absorbed from food source. The concentration of 
OH-PCBs in the environment is approximately 2.5 times higher than the 
concentration of PCBs [Turner, et al. 2007]. Higher concentrations of OH-PCBs were 
also detected in human and animal plasma than their parental PCBs [Park, et al 2009].  
As discussed above, PCBs mainly accumulate in adipose tissues. However, 
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OH-PCBs are more water soluble than their parent PCBs, and therefore have a 
different distribution in the body. Most OH-PCB congeners are readily conjugated and 
excreted. They are able to circulate with blood, cross blood-placenta barriers and 
reach various organs [Dreiem, et al. 2009]. Due to structural similarities, OH-PCBs 
are antagonist of several hormones, especially thyroxin (Figure 1.4). Studies have 
revealed a significant reduction of thyroid hormone levels in plasma of animals 
exposed to OH-PCBs. It has been found that OH-PCBs can bind to human 
transthyretin (TTR), a thyroid hormone transport protein, with an affinity even higher 
than the natural ligand thyroxin [Brouwer and Van den Berg, 1986]. Some OH-PCB 
congeners show estrogenicity and antiestrogenicity in various mammalian cells, 
which can inhibit gap junctional intercellular communication, activate aryl 
hydrocarbon and estrogen receptors, and eventually play a role in tumor promotion 
[Machala, et al. 2004]. Furthermore, studies have shown that PCB metabolites 
including OH-PCBs and PCB quinones bind to nucleophiles, such as glutathione 
(GSH), and inhibit topoisomerase II in vitro. As a consequence, cell susceptibility to 
oxidative damage increases due to the depletion of radical scavengers such as GSH 
[Srinivasan, et al. 2002]. In in vitro studies, the oxygen species (ROS) generated by 
OH-PCBs have also been shown to attack cellular DNA and other nucleophiles, 
resulting in oxidative damage, such as DNA strand breakage [Srinivasan, et al. 2001].  
 
 
Figure 1.4. Structure of thyroxin shows similarity with OH-PCBs. 
 
1.3 Detection methods for PCBs and OH-PCBs 
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With increasing public concerns over environmental accumulation and toxic 
effects of PCBs and OH-PCBs, much effort has been focused on developing 
techniques and methods to monitor these contaminants. Traditional methods used to 
detect PCBs and OH-PCBs include gas chromatography (GC) or high performance 
liquid chromatography (HPLC) coupled with mass spectroscopy [Berger, et al. 2004]. 
These methods require pretreatments of samples through extraction, cleanup, and 
derivatization. GC in combination with a compound specific detector is considered as 
the primary detection technique for PCBs. It requires the compounds to be thermally 
stable at the temperature at which the analyzed samples are being vaporized. The 
detection of OH-PCBs by GC/MS on the other hand requires a derivatization step due 
to their low volatility. Recently, a two-dimensional gas chromatography (GCGC) 
method has been developed to solve the problem of insufficient resolution of GC/MS. 
The GCGC system has higher sensitivity, enhanced separation capacities, and 
simplified sample preparation process [Harynuk and Marriott, 2006]. LC/MS/MS 
system is usually utilized when GC/MS is not applicable due to thermolability, low 
volatility and high polarity of target analytes, such as in the detection of 
dihydroxylated PCBs. Overall, despite considerable cost and labor intensive sample 
preparation steps, traditional analytical methods involving gas or liquid 
chromatography and mass spectrometry are highly sensitive and reproducible in the 
detection of target pollutants in the nano-gram per liter range [Beyer and Biziuk, 
2008].  
 
On the other hand, biosensors are becoming more and more popular in the 
analyses of environmental and laboratory samples due to multiple advantages, 
including simplified sample preparation, rapid analysis, high selectivity, and low cost 
[Liu, et al. 2010]. Furthermore, these biosensing systems, especially whole-cell 
sensing systems, can provide information on bioavailability and toxic effects of the 
analytes to a “living” organism, which is not easily assessed by other cell-disrupting 
methods.  
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Biosensors are sensing systems or devices that involve the utilization of 
biological components, such as antibodies, enzymes, and receptors as the recognition 
or trapping elements [Daunert, et al. 2000]. In the presence of specific targets, the 
transducing elements that are connected to the recognition components, such as a 
binding protein, will produce measurable signals. The intensity of the signal is 
correlated with the amounts of the specific targets. The biological sensing element 
therefore confers selectivity while the transducing element determines the sensitivity 
in the biosensor. Although the selectivity of biosensors is comparable or even higher 
than traditional chromatography methods, the relatively low sensitivity, difficulties 
with immobilizing the recognition element and limited shelf-life are some challenges 
that limit wide applications of biosensors [Namiesnik, 2001].  
 
1.4 Whole-cell biosensing system 
 
Whole-cell sensing systems offer many benefits over other types of biosensors. 
First of all, other biosensors and traditional chromatography methods usually measure 
the total concentrations of analytes. However, living organisms are not always 
actually exposed to such a high amount of analytes, particularly when the target 
analytes have low bioavailability. These results thus might overestimate the actual 
effective amount of the analyte that may affect the living environment of humans and 
wildlife. Living cells, on the other hand, can reflect the bioavailability of the analytes 
and their toxic effects more accurately. Secondly, owning to the self-reproducing 
ability of microorganisms, whole-cell sensing systems have advantages such as low 
cost and lack of need for complex regeneration [Van der Meer, et al. 2004].  
 
Microorganisms thriving in an environment with elevated concentration of 
chemicals have evolved different mechanisms to survive [Nikaido, 2009]. For 
example, many microbes living in hospitals have achieved increased resistance to 
multiple antimicrobials. The increased tolerance to alien chemicals could be a result 
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of an active efflux system that prevents the chemical from building up in their cytosol 
or special enzymes that degrade the compounds. The efflux pumps or enzymes 
involved in these mechanisms are usually encoded in the genome or plasmids of these 
microorganisms. However, the expression of these defense proteins is usually not 
constitutive. They are only produced in the presence of target compounds. The 
sensing and transcription regulation mechanism from different types of 
microorganisms have been exploited in the design of whole cell sensing systems for 
various toxic metals such as arsenic, antimony, mercury and lead, and organic 
aromatic compounds such as hydroxylated PCBs and chlorocatechols [Date, et al. 
2007]. 
 
In term of detection mechanisms, there are mainly two types that can be 
employed in the whole-cell biosensors, the constitutive expression mechanism and the 
inducible expression mechanism [Gu, et al. 2004]. The constitutive expression system 
expresses the reporter protein at all times and yields a signal constantly. Toxic 
compounds, once present in the microorganism growing environment, will interfere 
with the growth of cells. The resultant decrease of cell density is reflected from the 
reduction of the signals. By generating a standard curve, the concentration of toxic 
targets can be measured. The constitutive expression system is not very selective, as it 
will detect the presence of any toxin that affects the growth of cell. Therefore, it is 
useful in the assessment of the overall contents of toxic compounds in a sample. A 
mammalian cell line harboring a plasmid PEGFP-N2, in which GFP gene is under the 
transcriptional control of the CMV promoter, has been constructed [Bi, 2002]. Using 
this cells line, the toxicity of many chemicals was characterized. Under harmful or 
toxic conditions, cells exhibited a lower growth rate and metabolism, which was 
reflected from a decreased fluorescence value.  
 
In the inducible expression system, no signal can be detected in the absence of 
target compounds. The presence of the target compound triggers the expression of 
reporter proteins, which leads to detectable signals. The inducible expression system 
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is highly specific to analytes that induce the expression of the reporter protein. To 
construct a whole-cell biosensor of the inducible expression system, a special plasmid 
is usually created which includes a reporter gene under the control of a promoter as 
well as the gene coding for the corresponding regulator (Figure 1.5).  
 
Figure 1.5. Plasmid designed for whole-cell biosensor. A regulator is placed upstream of a 
promoter in order to control the expression of the reporter gene.  
 
The reporter gene/protein is the most universal component in a whole-cell 
biosensor. Reporters which are commonly used include LacZ/β-galactosidase, green 
fluorescent proteins (GFP), and prokaryotic or eukaryotic luciferases. Owning to their 
unique properties, these reporters can either lead to a color change in the solution or 
generate light signals at certain wavelengths with or without the addition of substrates 
[Gu, et al. 2004].  
LacZ/β-galactosidase is an enzyme which catalyzes the cleavage of lactose 
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into galactose and glucose. It also cleave orthor-nitrophenyl-β-galactoside (ONPG) to 
generate galactose and ortho-nitrophenol (Figure 1.6). The yellow color of 
ortho-nitrophenol is utilized to quantify β-galactosidase. By measuring the time it 
takes for a reaction to change color, expression level of β-galactosidase can be 
evaluated. Cleavage of other substrates such as 
methylumbelliferyl-β-D-galactopyranoside (MUG) yields fluorescent product, which 
has also been utilized for the development of β-galactosidase quantification methods 
[Daunert, et al. 2000].  
 
 
 
Figure 1.6. β-galactosidase catalyzes the cleavage of o-nitrophenyl-β-galactoside to generate a 
galactose and a yellow product, o-nitrophenol.  
 
GFP was first isolated from the jellyfish, Aequoria victoria. GFP and its 
homologs isolated from other marine creatures have been utilized as fluorescent 
markers for labeling purposes [Chudakov, et al. 2010]. GFP absorbs light at ~480 nm 
and emits green fluorescence at ~510 nm. The excitation and emission wavelength 
may undergo blue- or red-shift by the influence of specific amino acids in the 
environment [Chudakov, et al. 2010]. By measuring the intensity of fluorescence 
emitted, the amount of expressed GFP could be quantified, which reflects the quantity 
of target analytes. 
Luciferases were discovered and isolated from both prokaryotic cells such as 
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bacteria and eukaryotic cells such as firefly [Wilson and Hastings, 1998]. Their 
working mechanisms are slightly different. In bacteria, the continuous emission of 
bioluminescence requires five genes within the lux operon, luxCDABE. When 
substrates are added to the medium, only two genes, luxA and luxB, are required for 
light emission. Proteins LuxA and LuxB form a heterodimer which can catalyze the 
oxidation of their substrates, long-chain aldehydes, to fatty acids. This reaction 
involves the formation of an unstable high-energy bond and its breakage yields a blue 
light at around 490 nm. Proteins LuxC, LuxD and LuxE catalyze the formation of 
fatty aldehydes. Theses aldehydes will then serve as substrates for LuxA and LuxB to 
emit bioluminescence. In the presence of these three additional proteins (LuxC, LuxD 
and LuxE), there is no need for adding fatty aldehyde substrates. Firefly luciferase 
utilizes another type of working mechanism that is far more complicated than bacteria 
luciferase. It has been found that firefly luciferase is able to catalyze reactions to 
produce an unstable intermediate which soon degrades and leads to the emission of 
light (~550-570 nm) [Hastings, 1996]. The structure of substrates for firefly luciferase 
is also more complex than substrates for bacteria luciferase. In terms of application, 
both bacteria luciferases and firefly luciferase have been used in different biosensing 
systems [Taurianen, et al. 1998].  
 
A typical inducible expression whole-cell sensing system for the detection of 
OH-PCBs is shown in Figure 1.7. A plasmid containing hbpR-PhbpC-luxAB fusion as 
well as an ampicillin selectable marker was transformed into E. coli strain. hbpR gene 
codes for a regulatory protein, HbpR; PhbpC is the promoter for hbpC gene while 
luxAB codes for bacteria luciferase. hbpC gene belongs to a group of genes called hbp 
genes. The hbp genes were found from Pseudomonas azelaica strain HBP1, coding 
for enzymes catalyzing OH-PCB degradation. With these genes, HPB1 strain can 
metabolize and live on OH-PCBs as its main carbon source. The hpb gene cluster 
consists of three open reading frames, hbpC, hbpA and hbpD. And the expression of 
these genes is under the control of two promoters, PhbpC and PhbpA and regulated by 
one protein, HbpR. On Pseudomonas azelaica chromosome, HbpR is located 
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upstream of PhbpC to control the expression of downstream genes. In the absence of 
OH-PCBs, HbpR binds with PhbpC and prevents the expression of hbpC. The binding 
of OH-PCBs leads to a conformational change in HbpR, which triggered the release 
of HbpR from PhbpC. The release of PhbpC enables the production of HbpC to work on 
metabolizing OH-PCBs.  
 
This sensing and response mechanism is employed in the design of a 
biosensing system. Instead of hbpC gene, luxAB was fused downstream of PhbpC. The 
release of PhbpC thus activates the transcription of luxAB, producing bacteria 
luciferase. With the addition of the substrate n-decanal, the intensity of 
bioluminescence generated indicates the expression level of luciferase, which in turn 
reflects the concentration of inducer target compounds. Therefore, the light intensity 
is directly correlated with OH-PCB concentration [Turner, et al. 2007]. 
 
Figure 1. 7. Inducible expression whole-cell sensing system. A reporter gene is placed under the 
transcriptional promoter that is under the control of a regulator. (a) In the absence of analytes, the 
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regulator binds the promoter and prevents expression of the reporter gene. (b) After the addition of 
analytes, the regulator will bind with analytes instead of promoter. The release of promoter leads 
to the expression of the reporter gene. And reporter protein will generate signals with the addition 
of specific substrates.   
 
1.5 Efflux system of alien chemicals in Gram-negative bacteria 
 
Bacteria have adapted to thrive at many harsh conditions including in the 
presence of high concentrations of toxic metalloids such as arsenic and antimony, 
toxic metals such as chromium, lead and mercury, as well as harmful organic 
compounds. To survive under these conditions, the resourceful bacteria have evolved 
intricate mechanisms to reduce the impact of the toxins on their own metabolism. A 
well-studied example of the adaptive evolution of microbes is the emerging and 
prevalence of antimicrobial resistance in microbial pathogens infecting human and 
domestic animals. Due to years of intensive usage of antibiotic in the treatments of 
infections, bacteria exposed to antibiotics have developed several types of defense 
mechanisms. Some bacteria produce specific enzymes such as β-lactamases to break 
down or deactivate antibiotics. Bacteria become resistant to one drug or one type of 
drugs through this mechanism. Some bacteria alter their cellular components targeted 
by antibiotics through mutations or enzymatic modifications. The affinities between 
antibiotics and their targets are therefore reduced. The third mechanism involves 
multidrug resistance efflux pumps. Bacteria can flush drugs out of the cell through the 
multidrug efflux pumps located on their membranes, and thus reduced the 
intra-cellular concentration of antibiotics to a sub-toxic level that is not lethal to the 
microbe.  
 
Multidrug efflux pumps are encoded in the genomes of all bacteria. We 
speculate that these pumps might play a role in microorganisms used at the 
bioremediation site of PCBs. An analysis of E. coli genome reveals the existence of 
37 open reading frames encoding putative drug transporters [Nashino, 2001]. Nishino 
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et al. have shown that 20 out of them are clearly involved in drug resistance, but not 
all 20 drug exporters are constitutively expressed. These identified drug efflux pumps 
were also found to be able to recognize novel drugs which are still under development 
by pharmaceutical companies [Nashino, et al. 2009].  
 
Membrane transporters play an essential role in maintaining functionality of 
living cells. Other than protecting bacteria in a toxic environment, they keep ionic 
balances in between cytoplasm, periplasm and the outside environment by 
transporting ions such as Na
+
 and K
+
 across cell membranes. They also take up 
nutrients and exchange cellular communication molecules with the environment. 
There are more than 500 families of transporter systems belonging to several 
superfamilies, including the APT binding cassette (ABC) superfamily, the major 
facilitator superfamily (MFS), the resistance/nodulation/division (RND) superfamily, 
the amino acid-polyamine-organocation (APC) superfamily, and the voltage-gated ion 
channel (VIC) superfamily [Paulsen, 2003; Ren, et al. 2007]. Drug transporters in E. 
coli belong to five families, including MacAB from ABC superfamily, AcrAB from 
RND superfamily, EmrAB from MFS superfamily, Mdtk from multidrug and toxic 
compound exporters (MATE) family and EmrE from the small multidrug resistance 
(SMR) family. They work synergistically to build up the drug resistance of E. coli 
strains [Saier, et al. 2000; Pos, 2009].  
 
Multidrug pump systems in E. coli have been studies extensively. Individual 
gene was knocked out separately in order to determine the contribution of each pump 
system in the drug resistant mechanism by Sulavid et al. It turned out that among all 
the pump systems, AcrA-AcrB-TolC system is the dominant and constitutively 
expressed one while others are weakly expressed under normal conditions [Sulavik, et 
al. 2001].   
 
AcrA-AcrB-TolC is a tripartite protein complex with the structure shown in 
Figure 1.8. The AcrAB-TolC system has homologs in almost every gram-negative 
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bacterium strain. The major component AcrB is the multidrug efflux pump, belonging 
to the RND superfamily. Periplasmic fusion protein AcrA is the adaptor between AcrB 
and TolC and it contributes to the formation of a stable interaction between AcrB and 
TolC. TolC is a β-barrel protein located in the outer membrane. It functions as a 
channel to allow drugs passing through to the outside environment. TolC can also be 
employed by another pump system: EmrAB, to form another tripartite complex, 
EmrAB-TolC. The organization of AcrAB-TolC system provides effective protection 
for Gram-negative bacteria since once drugs are extruded to the outside environment, 
they have to traverse the outer membrane barrier again in order to reenter the cells 
[Nikaido and Takatsuka, 2009].  
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Figure 1.8. AcrAB-TolC transmembrane complex located in Gram-negative bacteria. TolC (pink) 
is the outer membrane channel. AcrB (green) locates at the interface of inner membrane and 
periplasm. AcrA (brown) works as an adapter between AcrB and TolC. 
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1.6 Protein AcrB  
 
As the inner membrane component of the complex which provides a pathway 
for drug transport, AcrB became the focus of many studies and has been well 
characterized. AcrB exists as a trimer. In 2002, the crystal structure of AcrB was 
solved by Murakami et al., which reveals that AcrB is an asymmetric homotrimer. 
Each of the AcrB monomers is made up of 1049 amino acids. Its N-terminal half 
shows sequence homology and structural similarity with the C-terminal half [Seeger, 
et al. 2008]. The transmembrane domain of AcrB is made up of twelve α-helices. The 
periplasmic part of AcrB contains a TolC docking and a pore forming domain. A 
central cavity is formed in the center of AcrB trimer structure where substrates enter 
and be captured. The co-crystallization of AcrB and its substrates shows that these 
compounds are inside the central cavity. A loop structure located at the top of TolC 
docking domain from each monomer extends into the adjacent monomer and this 
interaction stabilizes the AcrB trimer structure. A vestibule area was found at the 
interface of transmembrane domain and periplasm domain and was suggested to be 
the first site where drugs enter to reach the central cavity (Figure 1.9).  
 
AcrB employs a conformational cycling mechanism to export substrates, 
resembling that of a peristaltic pump. At any specific time, three monomers exhibit 
distinct conformations: loose (L), tight (T) and open (O). Each monomer rotates 
through these three conformations in turn (Figure 1.10). At the loose state, substrates 
enter the binding site. Then the monomer change conformation to the tight state in 
order to capture the substrate plus an H
+
 ion. Finally, it will change conformation 
again to the open state and pump substrates through the TolC channel while at the 
same time losing the H
+
. Through this mechanism, the transmembrane proton gradient 
is exploited to drive the conformational change that enabled the efflux of drugs 
[Seeger, et al. 2008; Pos, 2009]. 
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Figure 1.9. AcrB monomer structure. AcrB monomer contains a transmembrane domain, a pore 
forming domain, and the TolC docking domain. A loop structure extends into another AcrB 
monomer to stabilize AcrB trimer.  
 
 
Figure 1.10. Schematic representation of the AcrB conformational cycling transport mechanism. 
AcrB monomers are labeled different colors: orange, green and purple. The different geometric 
forms reflect conformational state loose (triangle), tight (rectangle), and open (circle). At Loose 
state, a substrate (indole) is fusing into AcrB. With a conformation change to tight state, AcrB 
exhibits high binding affinity to the substrate in the hydrophobic binding pocket. And finally, the 
substrate is released towards TolC following AcrB conformation changing to open state.  
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One characteristic of AcrB, similar with other multidrug efflux pumps, is that 
it has a wide range of substrates, including antibiotics (erythromycin, novobiocin, 
tetracycline, β-lactams, etc.), dyes (ethidium bromide, rhodamine 6G, crystal violet, 
Nile red, etc.), detergents (sodium dodecyl sulfate, Triton X-100, etc.), bile salts 
(cholate), and small organic molecules (hexane, cyclohexane, etc.) [Elkins and 
Nikaido, 2002; Takatsuka, et al. 2010]. These substrates can be charged or neutral, 
and differ dramatically in their molecular weights. However, these substrates show 
one thing in common: they all contain a large hydrophobic component. Accordingly, 
in terms of property, they are either hydrophobic or amphiphilic. Some examples of 
established AcrB substrates are shown in Figure 1.11. It was found that AcrB 
recognizes and picks up its substrates from the interface of inner membrane and 
periplasm where these lipophilic or amphiphilic molecules accumulate [Nikaido and 
Takatsuka, 2009]. This observation prompts us to examine the potential roles played 
by drug efflux pumps such as AcrB in the retention and efflux of PCBs and OH-PCBs, 
as such activities will affect the effectiveness of bioremediation of these compounds 
using microbes. 
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Figure 1.11. Structures of different substrates of AcrB 
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1.7 Summary 
 
As discussed above, PCBs and its metabolites OH-PCBs are hazardous 
environmental pollutants that have an adverse effect on the health of both human 
beings and wildlife. In this thesis research, I investigated the ability of a major 
multidrug efflux transporter protein, AcrB, to efflux PCBs and OH-PCBs from the 
cell. A wild-type E. coli strain (BW25113) and its corresponding acrB gene knock-out 
strain (BW25113∆acrB) were utilized to elucidate the potential role of AcrB in the 
uptake and retention of PCBs and OH-PCBs. PCB and OH-PCB toxicity assays were 
conducted using both strains to analyze the differences in their susceptibility. The 
accumulation of PCBs and OH-PCBs in the cells were first measured by GC/MS. 
Experimental results revealed that more of these compounds accumulated in the acrB 
gene knockout strain than the wild-type strain. I further confirmed this result using a 
genetically engineered whole-cell biosensing system to analyze OH-PCB 
concentrations in bacterial cytoplasm. A plasmid containing HbpR-PhbpC-luxAB fusion 
DNA was transformed into BW25113 and BW25113∆acrB. In the presence of 
OH-PCBs, the regulatory protein HbpR binds to the analyte instead of the promoter 
and triggers the expression of luciferase coded by luxAB gene. By measuring the 
bioluminescence intensity, the intracellular concentrations of OH-PCB in the two 
strains were compared. When the same concentration of OH-PCBs were added in cell 
cultures, higher intensity of bioluminescence had been recorded in BW25113∆acrB 
than in BW25113, indicating higher concentrations of OH-PCBs are present in the 
cytoplasm of BW25113∆acrB. My results suggest that PCBs and OH-PCBs are likely 
substrates for AcrB. The efflux activities of membrane transporters should be 
considered while designing bioremediation experiments.  
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Chapter II: Materials and Methods 
 
2.1 Reagents  
 
Polychlorinated biphenyls (names and correlated structures shown in Figure 
2.1) including PCB77, PCB104, PCB118, PCB126, PCB153, PCB166, PCB65 and 
PCB209, monohydroxylated polychlorinated biphenyls (names and correlated 
structures shown in Figure 2.2) including HPCB1001, HPCB2006, HPCB3001, 
HPCB4002 and HPCB5001, pyrene D-10 (C16D10) and 
N,O-Bis(trimethylsilyl)trifluoroacetamide with trimethylchlorosilane silylating 
reagent were purchased from AccuStandard Inc. (New Haven, CT). Dimethyl 
sulfoxide, sodium hydroxide, potassium hydroxide, ethylenediaminetetraacetic acid 
(EDTA), calcium dichloride dihydrate and kanamycin sulfate were purchased from 
BioWorld Inc. (Atlanta, GA). Hexane, isooctane, methylene chloride, hydrochloric 
acid and ferrous chloride were purchased from Fisher Scientific (Fair Lawn, NJ). 
Decanal, erythromycin, novobiocin, ampicillin, D-(+)-glucose, ammonium chloride, 
zinc sulfate heptahydrate, manganese sulfate monohydrate, copper sulfate 
pentahydrate, cobalt chloride, sodium borate, Luria-Bertani Broth, trypton, yeast 
extract, biotin, nicotinic acid and thiamine hydrochloride were purchased from 
Sigma-Aldrich (St. Louis, MO). Nitrilotriacetic acid was purchased from Fluka 
(Switzerland). Sulfuric acid and magnesium sulfate were purchased from EMD 
Chemicals (Gibbstown, NJ). All chemicals were reagents grade or better and were 
used as received.  
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Figure 2.1. Names and correlated structures of PCBs used in this study. 
 
Figure 2.2. Names and correlated structures of OH-PCBs used in this study. 
 
2.2 Bacterial strains and plasmids 
 
Wild-type Escherichia coli strain BW25113 and the corresponding acrB gene 
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knockout strain BW25113∆acrB (in which acrB gene was replaced by a kanamycin 
selectable marker) were obtained from Yale Coli Genetic Stock Center. E. coli strain 
DH10 harboring plasmid pHYBY109 was a kind gift from Dr. Sylvia Daunert. The 
plasmid pHYBY109 carries hbpR operon that confers resistance to OH-PCBs and 
LuxAB reporter gene coding for the bacteria luciferase as well as an ampicillin 
selectable marker. Plasmid pHYBY109 was transformed into BW25113 and 
BW25113∆acrB. All bacteria strains were preserved as glycerol stocks (15% glycerol) 
and kept at -80 ºC.  
 
2.3 Toxicity assay  
 
PCB stock solutions were prepared by dissolving individual PCBs in hexane at 
the concentration of 100 μg/mL. OH-PCB stock solutions were prepared by 
dissolving individual OH-PCBs in DMSO at the concentration of 10
-2
 M. Stock 
solutions were kept at 4 ºC. The stock solution was freshly diluted to the desired 
concentration right before each experiment.  
3 mL of overnight culture in LB were prepared for all strains. For 
BW25113∆acrB, 50 μg/mL kanamycin was added to the culture to prevent cross 
contamination. The cultures were incubated overnight at 37 
o
C on an orbital shaker 
(New Brunswick Scientific Excella E24 Incubator Shaker, New Brunswick, Edison, 
NJ) at 250 rpm. The next morning, the overnight cultures were diluted 1000 times in 
fresh LB medium. In parallel, PCBs or OH-PCBs were added into wells of sterile 
24-well cell culture plates (BioTek Inc., Winooski, VT). The solvent was allowed to 
evaporate. 800 μL of the diluted cell culture was then added into each well. The plates 
were shaken on a plate shaker at 37 
o
C, 220 rpm for 6 hours. The optical density of 
cells at 600 nm in each well was then measured using the Epoch multi-volume 
spectrometer system (BioTek Inc., Winooski, VT).  
 
2.4 Accumulation assay 
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2.4.1 Cell preparation  
 
An overnight culture of each strain was prepared by adding 50 μL fresh 
culture to 50 mL LB medium. The culture for BW25113∆acrB strain contained 50 
μg/mL kanamycin. Flasks were shaken at 37 oC on an orbital shaker at 250 rpm 
overnight. PCB and OH-PCBs stock solutions were added to autoclaved 250 mL 
Pyrex flasks and solvents were allowed to evaporate. Next, 100 mL LB medium and 
20 mL overnight culture were transferred into the flask containing either PCBs or 
OH-PCBs. The flasks were incubated at 37 
o
C in the orbital shaker at 220 rpm. 10 mL 
cultures were withdrawn after 1, 3, 5, 10, and 24 hours of incubation and processed as 
described below.  
 
2.4.2 Extraction and treatment 
 
10 mL cell culture was centrifuged using a Beckman Coulter Allegra 25R 
Centrifuge (Brea, CA) at 5000 rpm for 10 minutes. Cell pellets were resuspended in 
1.5 mL PBS buffer (one liter PBS buffer containing: 1.42 g of Na2HPO4, 8.0 g of 
NaCl, 0.27 g of KH2PO4 and 0.20 g of KCl, with pH adjusted to 7.4). The solutions 
were then transferred into pre-weighed Eppendorf tubes and centrifuged at 5000 rpm 
for 5 min. The tubes were decanted to remove the supernatant. The residual liquid was 
absorbed by Kimwipe tissue paper. Cell weights were measured from the difference 
between the weight of Eppendorf tubes with cell pellets and the weight of the empty 
tubes.  
 
Cells were then resuspended in 2 mL deionized water and immediately 
transferred to 5 mL VWR glass vials. After the addition of the recovery standard 
solution (100 μL PCB 166, 1.0 μg/mL for PCB accumulation assay or 300 μL 
HPCB1001, 2.0 μg/mL, for OH-PCB accumulation assay), cells were lysed using a 
Fisher Scientific sonicator (Hanover Park, IL). PCBs and OH-PCBs were then 
extracted by votex mixing the cell lysate with 2 mL of hexane for 20 min and shaken 
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on an orbital shaker at room temperature, 100 rpm for another 10 min to achieve 
higher extraction efficiency. Organic phase was transferred to another 5 mL glass vial. 
1 mL concentrated H2SO4 was added to remove lipids from the organic phase. After 
vortexed for 1 min, the sample was left overnight to allow the separation of the two 
phases. The next morning, the organic phase was withdrawn and concentrated to 100 
μL under a gentle stream of nitrogen.  
 
For PCB accumulation assay, the concentrated samples were transferred using 
a glass syringe to 1.5 mL Agilent GC/MS glass vials (with glass insert). 10 μL of 
internal standard PCB209 (1 μg/mL) was spiked into each sample before it was 
injected into GC/MS. An internal standard (ISTD) is a compound added to a sample 
in known concentration to facilitate the qualitative identification and/or quantitative 
determination of the sample components [IUPAC, 1997]. 
 
For OH-PCB accumulation assay, after the concentration of the sample, 100 
μL of silylating reagents (BSTFA: TMCS= 99:1, v/v) were added. The vials were then 
tightly capped and placed in a temperature controller (PolyScience Inc., Niles, IL) at 
60 
o
C for 40 min to allow the derivatization of hydroxyl groups in OH-PCBs. After 
derivatization, silylating reagents were evaporated. The dried solute was re-dissolved 
in 100 μL hexane. The solution was transferred into 1.5 mL Agilent GC/MS glass vial 
(with glass insert). 10 μL ISTD pyrene-d10 (1 μg/mL) was added as ISTD before the 
GC/MS analysis.  
 
2.4.3 GC/MS operation 
 
PCBs and OH-PCBs were analyzed using an Agilent 6890 Gas 
Chromatograph coupled with Agilent 5975 Inert Mass Selective Detector (Agilent, 
Santa Clara, CA). GC/MS conditions can be found in Table 2.1.  
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Capillary column: HP-5MS 5% Phenyl-Methyl Siloxane Column, Agilent 
Length: 30m; Internal Diameter: 0.25 mm; Film Thickness: 0.25 μm 
Carrier gas: Ultra-Pure Helium, 1.2 ml/min 
Injection mode: Splitless (Purge on at 0.75 min) 
Injection port temperature: 250 
o
C 
Oven temperature program: 
60 (hold 1 min, 40 
o
C /min)         200 
o
C ; 
200 
o
C (4 
o
C /min)         280 
o
C (hold for 5.5 min) 
Run time: 30 min 
✽ Inject hexane/methylene chloride between runs to reduce carry-over problem 
Table 2.1 GC/MS conditions applied in this study 
 
Calibration curves for different PCBs were established with seven 
concentration points for each species in the range of 0.05- 3.5 μg/mL (0.05, 0.1, 0.2, 
0.5, 1, 2, 3.5 μg/mL), each containing 0.1 μg/mL of ISTD (PCB209). Calibration 
curves for OH-PCBs were established with seven concentration points within the 
range of 0.1-10 μg/mL (0.2, 0.5, 1, 2, 5, 10 μg/mL), each containing 0.1 μg/mL of 
ISTD (pyrene-d10).  
 
The ratio of peak for each compound to that of the ISTD was used for 
quantification.  
 
2.5 Bioluminescence assay 
 
2.5.1 Preparation of cells harboring pHYBY109 
 
Plasmid pHYBY109 was transformed into BW25113 and BW25113∆acrB 
using the heat shock method [Froger, et al. 2007]. Overnight cultures for both 
BW25113 and BW25113∆acrB harboring plasmid pHYBY109 were prepared one 
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day before testing. For BW25113-pHYBY109, 50 mL LB medium containing 
ampicillin (100 μg/mL) was added in a 250 mL flask followed by the addition of 50 
μL fresh cell culture. The culture for BW25113∆acrB-pHYBY109 was made by 
adding 50 μL fresh cell culture to 50 ml LB medium containing kanamycin (50 μg/mL) 
and ampicillin (100 μg/mL). Flasks were kept at 37 oC on an orbital shaker at 250 rpm 
overnight.  
 
For the luciferase induction assay, 3 mL overnight cultures was transferred 
into each flask containing 50 mL mineral medium (MM) [Jaspers, et al. 2001]. 
OH-PCB stock solutions were then added to the desired concentration. All tests were 
prepared in triplicate. These flasks were placed at 30 
o
C on an orbital shaker at 225 
rpm for 5 h incubation period.   
 
Mineral medium (per liter) contains: 1.00 g of NH4Cl, 3.49 g of 
Na2HPO4·2H2O, 2.77 g of KH2PO4, 2.0 mL a vitamin solution, 20 mL Hunter’s 
vitamin-free mineral base, 0.01% trypton, 0.005% yeast extracts, and 10 mM 
D-(+)-glucose, adjusted to pH 6.8. The vitamin solution (per 100 mL) contained the 
following: 0.5 of mg biotin, 50 mg of nicotinic acid, and 25 mg of thiamine 
hydrochloride. Hunter’s vitamin-free mineral base (per liter) was prepared by mixing 
10 g of nitrilotriacetic acid, 6.0 g of KOH, 14.5 g of MgSO4·7H2O, 3.33 g of 
CaCl2·2H2O, 9.74 mg of (NH4)6MoO24·4H2O, 99 mg of FeSO4·7H2O and 50 ml 
Metal 44 Solution. The Metal 44 Solution (per 100 ml) contains 387 mg of 
Na4EDTA·4H2O, 1.10 g of ZnSO4·7H2O, 914 mg of FeSO4·7H2O, 154 mg of 
MnSO4·H2O, 39.2 mg of CuSO4·5H2O, 24.8 mg of Co(NO3)2·6H2O, 17.7 mg of 
NaB4O7·19H2O and it was neutralized with H2SO4. MM was sterilized and stored at 4 
o
C before use.  
 
2.5.2 Bioluminescence detection 
 
After the 5 hours incubation, 50 mL cell culture was centrifuged at 5000 rpm 
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for 10 min. Cell pellet was resuspended in 3 mL PBS buffer. For the final assay, 0.3 
mL of cell was transferred into a far UV quartz cuvette. Following the addition of 30 
μL n-decanal (50 mM in 1:1 ethanol/H2O), bioluminescence was immediately 
measured using a PerkinElmer LS55 Fluorescence Spectrometer (Waltham, MA) set 
at bioluminescence measurements. Light output was integrated from 5 s to 30 s and 
the total light signal was expressed as relative light unit (RLU).  
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Chapter III: Results and Discussion 
 
3.1 PCBs and OH-PCBs used in this study 
 
Five PCBs were selected as model compounds in this study, including PCB77, 
PCB104, PCB118, PCB126, and PCB153. Different levels of chlorination are present 
in the chosen PCBs, from four chlorine substitutions to six chlorine substitutions. 
Three of the PCBs (PCB77, PCB118, and PCB126) are co-planar congeners while the 
remaining two (PCB104 and PCB153) are non-planar congeners. PCBs were kept at 4 
o
C upon received and dissolved in hexane before performing tests.  
 
Although there are 837 possible monohydroxylated-PCB congeners, only 
limited numbers of these compounds are commercially available. Four 
monohydroxylated-PCBs were selected as target compounds in this study, including 
HPCB2006, HPCB3001, HPCB4002, and HPCB5001. All selected OH-PCBs contain 
one hydroxyl group substitution on carbon position 2 of the biphenyl structure. 
Different levels of chlorination are present in chosen OH-PCBs, from two chlorine 
substitutions in HPCB2006 to five chlorine substitutions in HPCB5003. The chosen 
OH-PCBs have been included in the study of a whole-cell biosensing system (Turner 
et al., 2007). OH-PCBs were kept at 4 
o
C and dissolved in DMSO before performing 
tests.  
 
3.2 PCB toxicity on E. coli   
 
Toxicity of chosen PCBs were determined in both wild-type E. coli strain 
BW25113 and an acrB gene knockout strain BW25113∆acrB. PCBs were applied as a 
mixture of all five PCBs and the total PCB concentration in cell cultures ranged from 
0.8 to 12.8 μg/mL. Optical densities of cells at 600 nm were measured after 6 hours of 
incubation (Figure 3.1).  
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Figure 3.1. Toxicity assay for PCB mixture in BW25113 (orange) and BW25113∆acrB (blue). AU, 
arbitrary unit. 
 
PCBs showed no toxicity at levels examined in both BW25113 and 
BW25113∆acrB, presumably due to the low solubility and bioavailability of these 
hydrophobic compounds.  
 
3.3 OH-PCB toxicity on E. coli 
 
Toxicity of chosen OH-PCBs was investigated in both BW25113 and 
BW25113∆acrB. Individual OH-PCB was tested separately in order to reveal the 
differences in their toxic effects. Different concentrations of OH-PCBs in the range 
from 0.4 to 6.4 μg/mL were present in cell cultures. Optical densities of cells at 600 
nm were measured after 6 hours incubation. Testing results for each OH-PCB along 
with the negative control are shown in Figure 3.2. to Figure 3.5. Data are normalized 
to the optical densities of the cell culture in the absence of OH-PCBs.  
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Figure 3. 2. Toxicity assay for HPCB2006 in BW25113 (orange) and BW25113∆acrB (blue). AU, 
arbitrary unit. 
 
Figure 3. 3. Toxicity assay for HPCB3001 in BW25113 (orange) and BW25113∆acrB (blue). AU, 
arbitrary unit. 
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Figure 3. 4. Toxicity assay for HPCB4002 in BW25113 (orange) and BW25113∆acrB (blue). AU, 
arbitrary unit. 
 
Figure 3. 5. Toxicity assay for HPCB5001 in BW25113 (orange) and BW25113∆acrB (blue). AU, 
arbitrary unit. 
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Different levels of toxicity were observed for different OH-PCBs as well as 
for the two E. coli strains. Among the four OH-PCBs tested, the levels of toxicity 
decreases from HPCB5001 to HPCB2006, and then to HPCB3001 and HPCB4002. 
BW25113 exhibits higher tolerance to OH-PCBs than BW25113∆acrB, indicating the 
significance of protein AcrB in conferring bacteria resistance toward OH-PCBs. 
Knocking out acrB gene directly leads to the lack of protein AcrB in the cell, through 
which BW25113∆acrB strain loses its major multidrug efflux pump. As a result, 
OH-PCBs accumulate in cells and cause lethal effects to the cells.  
 
3.4 PCB and OH-PCB accumulation assay in E. coli  
 
3.4.1 Establishment of GC/MS method 
 
All seven PCBs could be completely separated on the GC/MS chromatogram 
within 30 min under applied conditions. Each species displayed a single peak with a 
nice peak shape. A chromatogram of a sample containing mixed PCBs with each peak 
identified is shown in Figure 3.6. Target PCB identifications were confirmed by mass 
spectra as shown in Figure 3.7. The molecular ions [M+] of eight PCBs were 498, 292, 
292, 326, 326, 326, 360, and 360, for PCB209, PCB77, PCB65, PCB104, PCB118, 
PCB126, PCB153, and PCB166, respectively. The highest abundant fragment ion was 
utilized for quantification and analysis.  
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Figure 3.6 Gas chromatogram for model PCBs. AU, arbitrary unit.  
Peak identity: 1. PCB65; 2. PCB104; 3. PCB77; 4. PCB118; 5. PCB153; 6. PCB126; 7. PCB166; 
8. PCB209 (ISTD). 
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39 
 
C. 
 
 
D. 
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Figure 3.7 Mass spectra for five target PCBs: PCB77 (A), PCB104 (B), PCB118 (C), PCB126 (D), 
and PCB153 (E). The molecular ion [M
+
] for quantification is marked as bold black numbers on 
each plot.  
 
In this study, PCB166 were used as PCB recovery standards. Extraction 
recoveries for all PCBs at different incubation times ranged from 14.6% to 62.7%. 
Standard calibration curves for each PCB were shown in Figure 3.8. 
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E.  
 
 
F.  
 
Figure 3.8. Standard calibration curves and coefficient for all PCBs: PCB77 (A), PCB104 (B), 
PCB118 (C), PCB126 (D), PCB153 (E), and PCB166 (F). AU, arbitrary unit.  
 
3.4.2 Accumulation of PCBs in wild-type and acrB knockout E. coli 
 
As described in Chapter II, BW25113 and BW25113∆acrB cell cultures were 
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incubated in the presence of PCBs. At specified time, small portions of the cell culture 
were taken and processed to determine the PCB contents in the cell pellet. The 
quantity of PCB was normalized to the weight of the cell pellet. The accumulation 
data determined over time are shown in Figure 3.9.  
 
 
A.  
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E. 
 
Figure 3.9 PCB accumulation assay in BW25113 (orange) and BW25113∆acrB (blue). The 
concentrations of PCB in cell pellets collected at 1, 3, 5, 10, and 24 h were determined and 
normalized over the cell weight.  
 
Two observations were made through the accumulation studies: First, the 
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accumulation of PCB in cells did not increase over time. For BW25113, the level of 
PCBs remained stable within the error range over the time period collected. For 
BW25113∆acrB, the accumulation level reached the maximum value within one hour, 
and then decreased slightly over time. Second, comparing the one hour accumulation 
data, higher concentration of PCBs accumulated in BW25113∆acrB than in BW25113. 
This observation is consistent with our speculation that PCBs are substrates of AcrB. 
BW25113∆acrB lacked functional AcrB, and therefore was less effective in pumping 
out PCBs.  
 
While the same initial concentrations were used, different PCBs displayed 
different accumulation levels. The difference in accumulation could result from two 
factors: first, the differences in the AcrB efflux efficiency of various PCBs; second, 
the difference in the intrinsic solubility and bioavailability of the PCBs. The 
differences in the AcrB efflux efficiency are reflected from the differences in the PCB 
accumulation amounts in BW25113 and BW25113∆acrB. Through comparing, after 1 
hour of incubation, the accumulation levels of all five PCBs in BW25113 are 
approximately 44-50% of the level in BW25113∆acrB, indicating AcrB efflux the five 
PCBs with a similar efficiency (Table 3.1).  
 
To compare the intrinsic solubility and bioavailability of the PCBs, we 
compared the accumulation in the BW25113∆acrB strain (Figure 3.10). While the 
same concentration of PCBs existed in the cell culture, distinct accumulation levels 
were observed. Among all five PCBs, PCB126 has the highest while PCB153 has the 
lowest bioavailability. The bioavailability of PCBs is correlated with their structures. 
In this study, PCB126 and PCB77 have co-planar structures which lead to their 
relatively high water solubility and bioavailability, while PCB104, PCB118, and 
PCB153 have non-planar structures and thus low solubility and bioavailability. 
Therefore, distinguished accumulation levels of PCBs are likely due to differences in 
bioavailability of target PCBs.  
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Table 3.1 PCB accumulation in BW25113 and BW25113∆acrB with one hour incubation. 
BW25113                BW25113∆acrB            WT / ∆acrB                                                                                            
 (PCB/Cell Weight, μg/g)     (PCB/Cell Weight, μg/g)            (%)  
PCB77               99.96                     222.32                    44.90 
PCB104              64.73                     131.41                    49.26 
PCB118              69.98                     142.36                    49.17 
PCB126              106.90                    236.80                    45.14 
PCB153              49.81                     110.17                    45.24 
 
 
 
Figure 3.10. Accumulation of five PCBs in BW25113∆acrB with one hour incubation. PCB 
amounts are normalized to cell weights.  
 
One question remains to be answered, why the PCB level in BW25113∆acrB 
decreased over time. After 24 hours of incubation, the concentration of PCB in 
BW25113∆acrB decreased to a level comparable to the level in wild-type E. coli. On 
the contrary, the PCB level in the wild-type strain BW25113 remained at a constant 
level. We speculate that the presence of PCBs might have triggered the producing of 
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other efflux pumps which are coded in the bacteria genome.  
 
3.4.3 Accumulation of OH-PCBs in wild-type and acrB knockout E. coli 
 
The presence of the -OH group in monohydroxylated PCBs increases the 
difficulty in using GC for analysis, since it drastically reduced the volatility of the 
compound. Therefore, derivatization is necessary to overcome the low volatility of 
OH-PCBs. I tested two derivatization approaches, methylation and silylation. I found 
silylation was superior, because the reaction occurs in milder conditions than 
methylation, with shorter incubation time and relatively low temperature. Silylation 
procedure with BSTFA/TMCS reagent (at 60℃ for 40 min) for derivatization [Shi et 
al, 2009] is applied in this study. Silylating reaction of HPCB2006 is shown in Figure 
3.11.  
 
GC chromatograms were collected using silylated OH-PCBs. All four 
compounds were completely resolved as shown in Figure 3.12. Peaks were identified 
with standards as well as known spectra from the compound library. Molecular ions 
[M+] detected in each of OH-PCB silylation products were at 275, 310, 346, 380, and 
414, for HPCB1001, HPCB2006, HPCB3001, HPCB4002, and HPCB5001, 
respectively. An ion with the mass to charge ratio of 93 was selected for quantifying 
OH-PCBs. As shown in Figure 3.13, mass spectra for OH-PCB silylation products 
were obtained as well.  
 
In this study, pyrene-d10 was chosen as ISTD. HPCB1001 was used as 
recovery standard for OH-PCBs. The extraction recovery for all four OH-PCBs is in 
the range from 13.4% to 95.6%. The standard calibration curves for the OH-PCBs 
used in this study are shown in Figure 3.14. 
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Figure 3.11. HPCB2006 silylating reaction equation. 
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Figure 3.12. Gas chromatogram of a sample containing a mixture of silylated OH-PCBs. AU, 
arbitrary unit. Peak identity: 1. HPCB1001-Si(CH3)3; 2. HPCB3001-Si(CH3)3 ; 3. 
HPCB2006-Si(CH3)3 ; 4. HPCB4002-Si(CH3)3 ; 5. pyrene-d10 (ISTD); 6. HPCB5001-Si(CH3)3. 
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Figure 3.13. Mass spectra of four OH-PCB silylation products: HPCB2006 (A), HPCB3001 (B), 
HPCB4002 (C), and HPCB5001 (D). Chemical structures of targets are shown in the plots. Mass 
ion used for quantification is marked with a bold black number on each plot.    
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E.    
 
Figure 3.14. Standard calibration curves and coefficient of deviation from GC/MS for all OH-PCB 
silylation products: HPCB1001 (A), HPCB2006 (B), HPCB3001 (C), HPCB4002 (D), and 
HPCB5001 (E). AU, arbitrary unit.  
 
A mixture of four OH-PCBs was added to BW25113 and BW25113∆acrB to 
mimic the real samples in which PCB metabolites are present in a mixture. Total 
OH-PCB concentration in cell cultures reached 0.4 μg/mL (0.1 μg/mL of each 
OH-PCB, respectively) and was controlled at equal to or less than 0.4 μg/mL in the 
following tests. According to previous toxicity assays, OH-PCBs at these 
concentrations did not have a significant toxic effect. Accumulation of individual 
OH-PCB in cell strains was shown in Figure 3.15. Several observations were made. 
 
First, there is a drastic difference in OH-PCB accumulation levels between 
BW25113 and BW25113∆acrB. This result is consistent with previous observations 
with PCBs. Again, it supports the hypothesis that OH-PCBs are AcrB substrate. 
Second, in the wild-type strain BW25113, OH-PCB accumulation level maintained 
relatively constant up to 24 hours of incubation. While in the gene knockout strain 
BW25113∆acrB, the amount of PCB reduced with time. This observation is again 
similar to previous experimental results obtained for the accumulation experiment of 
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PCBs. Third, the efflux efficiencies of AcrB for different OH-PCBs were clearly 
different, as revealed by the difference between the accumulation levels of each 
OH-PCB in BW25113 and BW25113∆acrB (Table 3.2). Among four OH-PCBs, 
HPCB4002 accumulated in BW25113∆acrB 12 fold more than that in BW25113, 
suggesting high efflux efficiency of protein AcrB to transport HPCB4002. HPCB5001 
accumulation amount in BW25113∆acrB was only 1.5 fold more than the level in 
BW25113, which indicated that AcrB has relatively low efflux efficiency towards 
HPCB5001. Bioavaialbility of different OH-PCBs is reflected from the accumulation 
amount in BW25113∆acrB as shown in Figure 3.16. The accumulation level of 
HPCB2006 which has a co-planar structure is 3 fold the amount of HPCB3001 and 
HPCB4002, and 1.3 fold the amount of HPCB5001, suggesting its high bioavailability, 
while the other three OH-PCBs have non-planar structure which directly leads to their 
low bioavailability.  
 
 
A.  
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Figure 3.15. Accumulations of HPCB2006 (A), HPCB3001 (B), HPCB4002 (C), and HPCB5001 
(D) in BW25113 (orange) and BW25113∆acrB (blue). OH-PCB accumulations in E. coli were 
measured after 1, 3, 5, 10, and 24 h of incubation.  
 
Table 3.2 OH-PCB accumulation in BW25113 and BW25113∆acrB after one hour 
incubation 
                    BW25113                 BW25113∆acrB         WT / ∆acrB 
               (PCB/Cell Weight, μg/g)      (PCB/Cell Weight, μg/g)        (%)  
HPCB2006           1.441                      10.061                14.32 
HPCB3001           0.911                      3.487                 26.12 
HPCB4002           0.286                      3.248                 8.81 
HPCB5001           4.671                      6.933                 67.37 
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Figure 3.16. Accumulation of four OH-PCBs in BW25113∆acrB with one hour incubation. 
OH-PCB amounts are normalized to cell weights.  
 
To evaluate the effect of initial OH-PCB concentration on cellular 
accumulations, we measured HPCB2006 accumulation after 1 hour of incubation at 
three different concentrations, 0.1, 0.2, and 0.4 μg/mL. HPCB2006 accumulation in 
BW25113 and BW25113∆acrB after 1, 3, 5, 10, and 24 h of incubation were 
measured by GC/MS. As shown in Figure 3.17 and Figure 3.18, HPCB2006 
accumulation level correlates positively with initial concentrations. When HPCB2006 
concentration increases from 0.1 to 0.4 μg/mL, the accumulation in BW25113∆acrB 
increases from 1.5 fold to 4 fold of that in BW25113 strain. The results further 
confirm that protein AcrB works on extruding OH-PCBs. Additionally, the results 
suggest that the AcrB pump efflux efficiency is dependent on the amount of toxic 
compounds present. Moreover, OH-PCB accumulation decreases rapidly with time in 
BW25113∆acrB as comparing Figure 3.17 and Figure 3.18. The decrease ratio is 
dependent on the concentration of OH-PCBs. This observation is in agreement with 
previous results on PCBs and again we speculate that the presence of toxic 
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compounds such as OH-PCBs triggers the self-defense system in bacteria: other 
efflux pumps are therefore being expressed. The response, however, takes certain 
amount of time to be reflected from the compound accumulation results.  
 
 
Figure 3.17. HPCB2006 accumulation in BW25113 (Orange) and BW25113∆acrB (Blue) with 1 
hour of incubation in response to initial concentration applied.  
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Figure 3.18. HPCB2006 accumulation in BW25113 (Orange) and BW25113∆acrB (Blue) with 10 
hours of incubation in response to initial concentration applied.  
 
3.5 Bioluminescence assay  
 
The hbp genes enable P. azelaica to degrade hydroxylated biphenyls and use 
them as sole carbon sources. The mechanism involved has been well characterized 
[Kohler, et al. 1988]. A group of plasmids containing different hbp genes as well as 
promoters were constructed by Jaspers et al to further explore the characteristics of 
the promoter genes [Jaspers, 2000]. They found a transcription activator hbpR protein 
and two promoters that control the expression of hbp genes. Later, a plasmid 
(pHYBY109) containing hbpR-PhbpC-luxAB fusion was created and transformed into 
E. coli for the studying of PhbpC promoter activity [Jaspers, 2001]. Upon the addition 
of OH-PCBs, increase of bioluminescent signals was detected, suggesting the binding 
of OH-PCBs to HbpR leads to direct activation of the promoter PhbpC.  
 
In our study, the plasmid pHYBY109 was transformed to both wild-type E. 
coli strain BW25113 and acrB gene knockout strain BW25113∆acrB in order to 
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investigate the intracellular concentration of OH-PCBs. Based on our previous studies, 
more OH-PCBs accumulated in BW25113∆acrB than in BW25113. However, the 
above experiment could not differentiate the difference between OH-PCBs attached to 
the cell membrane and those entered into the cell. By using this bioluminescent 
whole-cell sensing system, we aimed at evaluating the differences of OH-PCB 
concentrations in the cytoplasm of the two strains.  
 
As shown in Figure 3.19, in the plasmid used in this study, hbpR, coding for 
the regulator HbpR protein, is placed upstream of the promoter PhbpC and the reporter 
luxAB, which codes for bacteria luciferase. In this way, the expression of luxAB is 
activated by the promoter PhbpC, which is directly regulated by HbpR. In the absence 
of OH-PCBs, HbpR binds with PhbpC, and prevents the expression of luciferase, while 
the addition of OH-PCBs triggers a conformational change in HbpR to release the 
promoter. As a result, expression of luxAB is induced. Bioluminescence is then 
measured immediately after the addition of the substrate.  
 
The mechanism involved in generating bioluminescence is shown in the 
following reaction:                                        
 
)500(22 nmhvRCPOOHFMNORCHOFMNH
luciferase    
 
Bacteria luciferase catalyzes the monooxygenation of a long-chain aldehyde to 
the corresponding carboxylic acid with production of light due to the decay of an 
exited state intermediate. Here we used decanal as the substrate. 
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Figure 3.19. Schematic representation of plasmid pHYBY109. 
 
Important assay parameters were optimized in order to improve the 
performance of the sensing system. Different incubation temperatures including 25 ºC, 
30 ºC, and 37 ºC, incubation length including 3, 5, and 7 hours as well as cell 
densities for the final bioluminescent assay were evaluated. Based on the sensitivity 
of the instrument, the optimum conditions under which the strongest bioluminescent 
signals can be measured, which are used in this study, are the following: the 
incubation temperature and time were set at 30 ºC for 5 hours; optical densities of 
cells in the final solution were at 3.0. The maximum bioluminescence emission 
wavelength was determined to be 500 nm. Immediately after addition of the substrate 
solution, the bioluminescent output was recorded. A bioluminescence emission curve 
can be observed. A representative emission spectrum is shown in Figure 3.20.  
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Figure 3.20. The bioluminescence emission curve of the whole-cell sensing system. The maximum 
emission wavelength is 500 nm. Light output from 5 s to 30 s was integrated for quantification of 
the bioluminescent signal. RLU, relative light unit.  
 
We chose to work in the OH-PCB concentration range from 0.1 to 3.2 or 6.4 
μg/ml, as higher OH-PCB concentration slowed down the growth of the knockout 
strain, which is more sensitive to the toxicity of OH-PCBs. An increase of the 
bioluminescent signals was detected with the increasing concentration of OH-PCBs, 
consistent with results reported in literature [Turner, et al. 2007]. Bioluminescent 
signals in both BW25113 and BW25113∆acrB were detected in the presence of four 
concentrations of each OH-PCB (Figure 3.21).  
 
Consistent with earlier toxicity and accumulation studies, different OH-PCBs 
have different efficiency in inducing the bioluminescent signal (Figure 3.21). 
However, all four OH-PCBs tested induced significantly higher signals in 
BW25113∆acrB compared to BW25113. The stronger signals in BW25113∆acrB 
suggested a higher cytoplasmic OH-PCB concentration in the acrB knockout strain.  
 
For three OH-PCBs tested, HPCB2006, HPCB3001, and HPCB5001, the 
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bioluminescent levels in the wild-type strain BW25113 were constant at different 
OH-PCB level (Figure 3.21). For HPCB4002, an increase of OH-PCB concentration 
in the cell culture did result in an increase of the bioluminescent signal. On the 
contrary, all OH-PCBs induced the emission of bioluminescent signal in a 
concentration dependent manner in BW25113∆acrB.  
 
This result indicates that protein AcrB does interact with OH-PCBs and 
functions on efflux these toxic compounds out of cells. Therefore, with absence of 
protein AcrB, OH-PCBs are more likely to stay inside the cells and causing damage to 
the cell. 
 
A. 
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C.  
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Figure 3.21. Bioluminescent signal of BW25113 (orange) and BW25113∆acrB (blue) in the 
presence of OH-PCBs: HPCB2006 (A), HPCB3001 (B), HPCB4002 (C), and HPCB5001 (D). 
Data are the integration of bioluminescent signals from 5 s to 30 s divided by optical densities of 
cells at 600 nm in the final testing solutions. RLU, relative light unit.  
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Chapter IV: Conclusions  
 
In this project, the interaction between a major multi-drug efflux transporter 
protein, AcrB, and PCBs as well as their metabolites, OH-PCBs, was investigated 
through the use of a wild-type E. coli strain BW25113 and its corresponding acrB 
gene knockout strain BW25113∆acrB strain. I have found that PCBs have little toxic 
effects to both E. coli strains, presumably due to low bioavailability. Different 
OH-PCBs have distinguished levels of toxic effects. By measuring PCB and OH-PCB 
accumulation in both cell strains using GC/MS, apparent differences were observed 
between BW25113 and BW25113∆acrB. PCBs and OH-PCBs accumulate more in 
BW25113∆acrB than in BW25113, suggesting protein AcrB functions in extruding 
these compounds out of cells. The results are in agreement with the bioluminescent 
assays using a whole-cell sensing system. With the same concentration of OH-PCBs 
in the cell culture, a higher level of OH-PCBs enters the cytoplasm of 
BW25113∆acrB than BW25113. My results indicate that PCBs and OH-PCBs are 
likely to be substrates of protein AcrB. Therefore, AcrB can recognize and transport 
PCBs and OH-PCBs out of cells. This finding suggests that the potential role of efflux 
pumps should be considered while using microbes in bioremediation applications 
involving PCBs and OH-PCBs. 
 
 
 
 
 
 
 
 
 
Copyright © Shen Geng 2011 
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